Pharmsville Co. Ltd
Pharmsville Co., Ltd. produces and sells functional health food in South Korea. The company also exports its products. It offers its products under the Apple Tree Dr. Kim, Devil Diet, Sang Sang Bang, Vitamin Story, Apple Tree, Golden Garden, Daily Green, Wilac, Doctor Solution, and PS brands. Pharmsville Co., Ltd. was founded in 2000 and is headquartered in Seoul, South Korea.
Pharmsville Co. Ltd - Asset Resilience Ratio
Pharmsville Co. Ltd (318010) has an Asset Resilience Ratio of 54.16% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2017–2024)
This chart shows how Pharmsville Co. Ltd's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down Pharmsville Co. Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩0.00 | 0% |
| Short-term Investments | ₩37.10 Billion | 54.16% |
| Total Liquid Assets | ₩37.10 Billion | 54.16% |
Asset Resilience Insights
- Very High Liquidity: Pharmsville Co. Ltd maintains exceptional liquid asset reserves at 54.16% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company has significant short-term investments, indicating active treasury management.
Pharmsville Co. Ltd Industry Peers by Asset Resilience Ratio
Compare Pharmsville Co. Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF |
Drug Manufacturers - Specialty & Generic | -0.02% |
|
Kamada
NASDAQ:KMDA |
Drug Manufacturers - Specialty & Generic | 21.63% |
|
Dongwha Pharm.Co.Ltd
KO:000020 |
Drug Manufacturers - Specialty & Generic | 1.92% |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078 |
Drug Manufacturers - Specialty & Generic | 0.46% |
|
Yuhan Corp.
KO:000100 |
Drug Manufacturers - Specialty & Generic | 0.99% |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153 |
Drug Manufacturers - Specialty & Generic | 1.81% |
|
Kotra Industries Bhd
KLSE:0002 |
Drug Manufacturers - Specialty & Generic | 9.82% |
|
Yuyu Pharma Inc
KO:000227 |
Drug Manufacturers - Specialty & Generic | 1.74% |
Annual Asset Resilience Ratio for Pharmsville Co. Ltd (2017–2024)
The table below shows the annual Asset Resilience Ratio data for Pharmsville Co. Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 56.11% | ₩37.67 Billion | ₩67.14 Billion | +0.63pp |
| 2023-12-31 | 55.48% | ₩39.54 Billion | ₩71.28 Billion | -1.76pp |
| 2022-12-31 | 57.24% | ₩42.83 Billion | ₩74.83 Billion | +1.08pp |
| 2021-12-31 | 56.16% | ₩41.73 Billion | ₩74.31 Billion | +3.58pp |
| 2020-12-31 | 52.58% | ₩36.30 Billion | ₩69.04 Billion | -5.14pp |
| 2019-12-31 | 57.72% | ₩39.14 Billion | ₩67.81 Billion | +14.95pp |
| 2018-12-31 | 42.76% | ₩14.31 Billion | ₩33.47 Billion | +3.19pp |
| 2017-12-31 | 39.58% | ₩11.44 Billion | ₩28.90 Billion | -- |